Ventritex
portfoliocompanies
company snapshot
Ventritex established itself in the 1980s as a leading maker of implantable defibrillators, surgically implanted devices that automatically correct potentially lethal abnormal heart rhythms known as cardiac arrhythmias. Ventritex completed an IPO in 1993, and was acquired by St. Jude Medical in 1997.